Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
A tissue cultured allogeneic dermal substitute is a specialized medical product used to treat wounds or skin defects on the trunk, arms, or legs. This substitute is derived from human fibroblast cells, which are essential components of the skin that help in the healing process. The fibroblasts are typically sourced from newborn foreskin tissue and are cultured in a laboratory setting. During this process, the fibroblasts are seeded onto a bioabsorbable mesh scaffold, which serves as a framework for the cells to grow and multiply. As the fibroblasts proliferate, they produce important substances such as human dermal collagen, matrix proteins, growth factors, and cytokines. These components play a crucial role in regulating the immune response and promoting healing. The end result is a metabolically active, living dermal substitute that can effectively cover and protect the wound site. When applying the dermal substitute, it is carefully removed from its transport container and placed onto a prepared wound bed. The substitute is then secured in place using sutures or staples to ensure it remains stable during the healing process. Following this, a layered dressing is applied to the area, which typically includes a nonadherent layer to prevent sticking, a bulky layer of gauze for absorption, a compression layer to support the area, and an anti-shear layer to minimize friction. For billing purposes, CPT® Code 15360 is used for the initial application of the first 100 square centimeters or less in adults, or for 1% of total body surface area (TBSA) in infants and children. CPT® Code 15361 is then utilized for each additional 100 square centimeters in adults or each additional 1% of TBSA in infants and children, or any part thereof.
© Copyright 2026 Coding Ahead. All rights reserved.
The tissue cultured allogeneic dermal substitute is indicated for use in patients requiring coverage for wounds or skin defects located on the trunk, arms, or legs. This procedure is particularly relevant for individuals with extensive skin loss or damage, where traditional wound healing methods may be insufficient. The use of this dermal substitute is appropriate for both adults and pediatric patients, including infants and children, who may have varying percentages of total body surface area affected by wounds.
The application of a tissue cultured allogeneic dermal substitute involves several critical steps to ensure proper placement and effectiveness. First, the wound bed must be adequately prepared, which may include cleaning the area and removing any necrotic tissue to promote optimal healing conditions.
Post-procedure care is essential to ensure the success of the tissue cultured allogeneic dermal substitute application. Patients are typically monitored for signs of infection or complications at the wound site. The layered dressing should remain intact and be changed according to the healthcare provider's instructions, which may vary based on the specific needs of the wound and the patient's overall condition. Patients may also receive guidance on how to care for the area, including instructions on keeping the site clean and dry. Follow-up appointments are important to assess the healing progress and determine if additional treatments or interventions are necessary.
| Short Descr | APLY CULT DERM SUB T/A/L ADD | Medium Descr | TISSUE CLTR ALGC DERMAL T/A/L EA 100CM/EA 1 PCT | Long Descr | TISSUE CLTR ALGC DERMAL T/A/L EA 100CM/EA 1 PCT | Status Code | Active Code | Global Days | ZZZ - Code Related to Another Service | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 1 - Statutory payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 172 - Skin graft |
Get instant expert-level medical coding assistance.